ADME and Toxicology
Miner3D data analysis of multivariate data in your compounds databases allows you to identify potential issues in early phases of the development cycle.
By including the biological, chemical and ADME data you can optimize drug design as well as drug’s synthesis paths and drug’s formulation.
Chemical properties data given into context with stability, metabolism and toxicity information observed from laboratory tests allows you to improve management of a new drug’s finalization.
Pharmacokinetics, absorption and toxicology groups teaming up with both specialists on design and synthesis as well as with specialists on clinical trials can be working on the same analyses within the visual environment of Miner3D. This collaboration may positively influence both ends of the drug design process and then, at the bottom line, save time to market and economize project’s planning, management and budget.